Agreements

Date: 2016-11-28

Type of information: Production agreement

Compound: autologous cell therapy products

Company: Lion Biotechnologies (USA - CA) WuXi AppTec (China)

Therapeutic area: Technology - Services

Type agreement: manufacturing - production

Action mechanism: cell therapy

Disease:

Details:

• On November 28, 2016, Lion Biotechnologies announced that it has entered into a new three-year manufacturing services agreement and related statements of work with WuXi AppTec to manufacture and perform services related to the manufacture of its autologous cell therapy products.

Financial terms:

Latest news:

TOP